Two Seas Capital
Latest statistics and disclosures from Two Seas Capital's latest quarterly 13F-HR filing:
- Top 5 stock holdings are INDV, ROIV, ABUS, IMVT, Esperion Therapeutics Inc Ne, and represent 82.66% of Two Seas Capital's stock portfolio.
- Added to shares of these 10 stocks: VST (+$14M), Core Scientific (+$14M), ARQT (+$6.4M), AVDL (+$5.4M), GOOGL, SHC, Esperion Therapeutics Inc Ne, IMVT, Core Scientific Inc New Wt Exp 012329, TRML.
- Started 8 new stock positions in AVDL, GOOGL, Core Scientific Inc New Wt Exp 012329, Core Scientific, SHC, TRML, VST, Core Scientific.
- Reduced shares in these 9 stocks: , ESPR (-$9.4M), INDV (-$9.0M), META, ABUS, HTZ, HTZWW, OMEX, SONO.
- Sold out of its positions in HTZWW, HTZ, MMM.
- Two Seas Capital was a net buyer of stock by $15M.
- Two Seas Capital has $511M in assets under management (AUM), dropping by 2.65%.
- Central Index Key (CIK): 0001823138
Tip: Access up to 7 years of quarterly data
Positions held by Two Seas Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Two Seas Capital
Two Seas Capital holds 18 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Indivior Ord (INDV) | 55.6 | $284M | -3% | 13M | 21.42 |
|
| Roivant Sciences SHS (ROIV) | 16.4 | $84M | 7.9M | 10.54 |
|
|
| Arbutus Biopharma (ABUS) | 4.0 | $20M | -5% | 7.8M | 2.58 |
|
| Immunovant (IMVT) | 3.4 | $18M | +5% | 541k | 32.31 |
|
| Esperion Therapeutics Inc Ne Note 4.000%11/1 (Principal) | 3.3 | $17M | +17% | 20M | 0.83 |
|
| Meta Platforms Cl A (META) | 3.0 | $16M | -11% | 32k | 485.58 |
|
| Vistra Energy (VST) | 2.7 | $14M | NEW | 197k | 69.65 |
|
| Core Scientific | 2.7 | $14M | NEW | 3.8M | 3.54 |
|
| Esperion Therapeutics (ESPR) | 2.2 | $11M | -45% | 4.2M | 2.68 |
|
| Arcutis Biotherapeutics (ARQT) | 1.6 | $8.0M | +391% | 809k | 9.91 |
|
| Sonos (SONO) | 1.5 | $7.7M | 404k | 19.06 |
|
|
| Avadel Pharmaceuticals Sponsored Adr (AVDL) | 1.1 | $5.4M | NEW | 318k | 16.89 |
|
| Odyssey Marine Expl Com New (OMEX) | 0.9 | $4.7M | -9% | 1.2M | 3.81 |
|
| Alphabet Cap Stk Cl A (GOOGL) | 0.7 | $3.7M | NEW | 24k | 150.93 |
|
| Sotera Health (SHC) | 0.7 | $3.6M | NEW | 300k | 12.01 |
|
| Core Scientific *w Exp 01/23/202 | 0.1 | $563k | NEW | 234k | 2.41 |
|
| Tourmaline Bio (TRML) | 0.1 | $501k | NEW | 22k | 22.90 |
|
| Core Scientific *w Exp 01/23/202 | 0.1 | $373k | NEW | 280k | 1.33 |
|
Past Filings by Two Seas Capital
SEC 13F filings are viewable for Two Seas Capital going back to 2021
- Two Seas Capital 2024 Q1 filed May 15, 2024
- Two Seas Capital 2023 Q3 filed Nov. 14, 2023
- Two Seas Capital 2023 Q2 filed Aug. 14, 2023
- Two Seas Capital 2023 Q1 filed May 15, 2023
- Two Seas Capital 2022 Q4 filed Feb. 14, 2023
- Two Seas Capital 2022 Q3 filed Nov. 14, 2022
- Two Seas Capital 2022 Q2 filed Aug. 12, 2022
- Two Seas Capital 2022 Q1 filed May 13, 2022
- Two Seas Capital 2021 Q4 filed Feb. 14, 2022